We are live on ! Find out more
STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

69 hedge funds and large institutions have $96.2M invested in Stemline Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

53% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 15

48% more call options, than puts

Call options by funds: $253K | Put options by funds: $171K

42% more capital invested

Capital invested by funds: $67.8M → $96.2M (+$28.4M)

13% more funds holding

Funds holding: 61 → 69 (+8)

Holders
69
Holders Change
+8
Holders Change %
+13.11%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
23
Reduced
15
Closed
7
Calls
$253K
Puts
$171K
Net Calls
+$82K
Net Calls Change
+$78K

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$2.09M
2
CCI
Columbus Circle Investors
+$1.18M
3
SM
Sabby Management
Florida
+$797K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$553K
5
BIT
BlackRock Institutional Trust
California
+$421K

Top Sellers

Rank Fund Capital Flow
1
TCM
TimesSquare Capital Management
New York
-$6.43M
2
Franklin Resources
Franklin Resources
California
-$3.74M
3
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
-$1.21M
4
RA
Royce & Associates
New York
-$777K
5
OAM
Oxford Asset Management
United Kingdom
-$616K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$539K -$19.3K -2,375 -5%
Mackenzie Financial
27
Mackenzie Financial
Ontario, Canada
$400K -$1.21M -149,370 -80%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$400K +$300K +36,929 New
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$386K +$2.44K +300 +0.8%
SIP
30
Stoneridge Investment Partners
Pennsylvania
$365K -$1.34K -165 -0.5%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$338K – – –
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$337K – – –
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$310K -$39K -4,794 -14%
TA
34
Teachers Advisors
New York
$291K +$33K +4,060 +18%
Charles Schwab
35
Charles Schwab
California
$282K – – –
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$272K -$9.38K -1,153 -4%
CD
37
Carl Domino
Florida
$267K -$2.48K -305 -1%
PAM
38
Paradigm Asset Management
New York
$255K +$22K +2,700 +13%
TC
39
TFS Capital
Pennsylvania
$253K +$190K +23,324 New
TI
40
Telemetry Investments
New York
$249K -$155K -19,121 -45%
SOMRS
41
State of Michigan Retirement System
Michigan
$217K +$163K +20,000 New
ORI
42
Oak Ridge Investments
Illinois
$139K +$21.7K +2,663 +26%
Goldman Sachs
43
Goldman Sachs
New York
$132K +$98.9K +12,158 New
NFA
44
Nationwide Fund Advisors
Ohio
$120K -$92.3K -11,353 -51%
PA
45
Perceptive Advisors
New York
$116K -$552K -67,901 -86%
AIG
46
American International Group
New York
$105K +$114 +14 +0.1%
BA
47
BlackRock Advisors
Delaware
$97K +$13.8K +1,697 +23%
UBS Group
48
UBS Group
Switzerland
$90K +$6.59K +811 +11%
Wells Fargo
49
Wells Fargo
California
$84K – – –
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$60K +$44.5K +5,478 New
1
2
3

STML Hedge Fund Activity: Q3 2016 in Review

69 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Stemline Therapeutics, Inc. (STML) for Q3 2016, worth a combined $96.2M — up 42% from $67.8M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new STML positions and 7 closed out — a net gain of 8 holders — while 23 added to existing stakes and 15 trimmed.

The largest buyer was Candriam SCA, opening a new position worth an estimated $2.09M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $6.43M sold.

  • 69 institutional investors held Stemline Therapeutics, Inc. (STML) as of Q3 2016, up from 61 in Q2 2016.
  • Funds reported $96.2M of Stemline Therapeutics, Inc. stock for Q3 2016, up 42% quarter-over-quarter.
  • 15 funds opened new Stemline Therapeutics, Inc. positions in Q3 2016 and 7 closed out, a net change of +8 holders.
  • The largest Stemline Therapeutics, Inc. buyer in Q3 2016 was Candriam SCA, an estimated $2.09M added.
  • The largest Stemline Therapeutics, Inc. seller in Q3 2016 was TimesSquare Capital Management, an estimated $6.43M sold.

Based on aggregated 13F filings for Q3 2016.